MENU
LYEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lyell Immunopharma (LYEL) Earnings Date & Reports

Lyell Immunopharma Inc is a clinical-stage cell therapy company... Show more

A.I. Advisor
published Earnings

LYEL is expected to report earnings to fall 75.89% to -17 cents per share on May 13

Lyell Immunopharma LYEL Stock Earnings Reports
Q1'25
Est.
$-0.17
Q4'24
Missed
by $0.51
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.18
Q1'24
Missed
by $0.02
The last earnings report on March 12 showed earnings per share of -70 cents, missing the estimate of -19 cents. With 723.93K shares outstanding, the current market capitalization sits at 139.14M.
View a ticker or compare two or three
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
201 Haskins Way
Phone
+1 650 695-0677
Employees
224
Web
https://www.lyell.com